Biotechs have emerged as an interesting option for investors. The State Street SPDR S&P Biotech ETF (XBI) broke out above a buy point last week and remains in that price area. The biotech fund is one of two ETFs in IBD Leaderboard.
The S&P 500 Biotech index gapped up to nearly an all-time high last Wednesday, a bullish day for…
Extract — continue reading at the source.
Related stories
'Moneymaxxing' is the latest personal finance trend. Will it work for you?
‘We got attacked’: Canadians unite in fury against Trump’s latest tariff salvo
CrowdStrike’s stock soars after AI fuels the cybersecurity company’s ‘best quarter’ ever
Nvidia sales more than double to $96bn on bumper AI demand
Salesforce’s stock surges as AI momentum fuels revenue growth
I just had my first baby and don’t want to go back to work. Is quitting for a year a bad idea?